SCHEMBL6846418

SCHEMBL6846418

O=[PH](OC(F)(F)Br)OC(F)(F)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959418 0.80
SCHEMBL6846419 0.75
SCHEMBL641075 0.72
SCHEMBL5858895 0.67
SCHEMBL20394576 0.65
SCHEMBL10991808 0.64
SCHEMBL269083 0.64
SCHEMBL4959422 0.63
SCHEMBL18740711 0.63
SCHEMBL1094918 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111018708-A Synthesis method of difluoroalkyl substituted aromatic ketone compound under photocatalysis 浙江工业大学 2020-04-17 CN claimed
CN-110803972-A Synthesis method of difluoroalkyl substituted aromatic aldehyde compound under photocatalysis 浙江工业大学 2020-02-18 CN claimed
US-20240239778-A1 GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-07-18 US disclosed
CN-118317963-A TRPML modulators, compositions thereof, and methods of use 卡拉韦治疗公司 2024-07-09 CN disclosed
CN-118302417-A NLRP3 inhibitors PTC医疗公司 2024-07-05 CN disclosed
WO-2024140679-A1 SPIROCYCLIC HPK1 ANTAGONISTS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2024-07-04 WO disclosed
EP-4392414-A1 INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2024-07-03 EP disclosed
CN-118159537-A 6-Aza-quinoline derivatives and related uses 黑钻治疗公司 2024-06-07 CN disclosed
WO-2024115733-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS REWIND THERAPEUTICS NV (BE) 2024-06-06 WO disclosed
CN-118119619-A SIK inhibitor and composition, preparation method and application thereof 上海美悦生物科技发展有限公司 2024-05-31 CN disclosed
CN-118119603-A Substituted benzamides as herbicides 先正达农作物保护股份公司 2024-05-31 CN disclosed
US-10220034-B2 Hepatitis B viral assembly effectors INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2019-03-05 US disclosed
CN-108884050-A Tetrahydroisoquinoline derivatives UCB生物制药私人有限公司 2018-11-23 CN disclosed
CN-107108672-A The five rings imdazole derivatives of fusion UCB生物制药私人有限公司 2017-08-29 CN disclosed
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 WO disclosed
US-20160271130-A1 HEPATITIS B VIRAL ASSEMBLY EFFECTORS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) 2016-09-22 US disclosed
WO-2015142670-A1 ANTI-DIABETIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD TO TREAT DIABETES MEDISYN TECHNOLOGIES, INC. (US) 2015-09-24 WO disclosed
US-6777433-B2 BIS((DIFLUORO-PHOSPHONATO-METHYL)PHENYL) DERIVATIVES; ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK FROSST CANADA & CO. (CA) 2004-08-17 US disclosed
US-20030114703-A1 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates MERCK FROSST CANADA LTD. (CA) 2003-06-19 US disclosed
US-5599639-A Acid-modified polybenzimidazole fuel cell elements HOECHST CELANESE CORPORATION (US) 1997-02-04 US disclosed